Amgen (AMGN) Earnings Date, Estimates & Call Transcripts $300.08 -1.86 (-0.62%) Closing price 08/5/2025 04:00 PM EasternExtended Trading$297.97 -2.11 (-0.70%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Amgen Earnings Summary Amgen released Q2 2025 earnings on August 5, 2025, reporting an EPS of $6.02, which topped the consensus estimate of $5.28 by $0.74. Quarterly revenue rose 9.4% year-over-year to $9.18 billion, above analysts' expectations of $8.86 billion. With a trailing EPS of $10.96 and a P/E Ratio of 27.38, Amgen's earnings are expected to grow 3.73% next year, from $20.62 to $21.39 per share. Latest Q2 Earnings DateAug. 5EstimatedConsensus EPS (Aug. 5) $5.28 Actual EPS (Aug. 5) $6.02 Beat By $0.74 Actual Revenue (Aug. 5) $9.18BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Amgen Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amgen and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAMGN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AMGN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Amgen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20253$3.95$4.45$4.19Q2 20253$5.20$5.67$5.36Q3 20253$5.32$5.66$5.48Q4 20253$5.12$5.48$5.28 FY 2025 12 $19.59 $21.26 $20.31 Q1 20262$4.42$4.60$4.51Q2 20262$5.00$5.24$5.12Q3 20262$5.24$5.29$5.27Q4 20262$4.77$5.34$5.06 FY 2026 8 $19.43 $20.47 $19.95 Q1 20271$4.94$4.94$4.94 Amgen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025$5.28$6.02+$0.74$2.65$8.86B$9.18B5/1/2025Q1 2025$4.18$4.90+$0.72$3.20$8.05B$8.15B2/4/2025Q4 2024$5.04$5.31+$0.27$1.16$8.87B-10/30/2024Q3 2024$5.11$5.58+$0.47$5.94$8.50B$8.50B8/6/2024Q2 2024$5.01$4.97 -$0.04$8.56$8.35B$8.39B5/2/2024Q1 2024$3.76$3.96+$0.20$8.13$7.45B$7.45B2/6/2024Q4 2023$4.66$4.71+$0.05$8.00$8.13B$8.20B10/31/2023Q3 2023$4.65$4.96+$0.31$6.70$6.92B$6.90B Amgen Earnings - Frequently Asked Questions When is Amgen's earnings date? Amgen has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on AMGN's earnings history. What guidance has Amgen issued on next quarter's earnings? Amgen updated its FY 2025 earnings guidance on Tuesday, August, 5th. The company provided EPS guidance of 20.200-21.300 for the period, compared to the consensus EPS estimate of 20.889. The company issued revenue guidance of $35.0 billion-$36.0 billion, compared to the consensus revenue estimate of $35.3 billion. Did Amgen beat their earnings estimates last quarter? In the previous quarter, Amgen (NASDAQ:AMGN) reported $6.02 earnings per share (EPS) to beat the analysts' consensus estimate of $5.28 by $0.74. Learn more on analysts' earnings estimate vs. AMGN's actual earnings. How can I listen to Amgen's earnings conference call? The conference call for Amgen's latest earnings report can be listened to online. Listen to Conference Call How can I read Amgen's conference call transcript? The conference call transcript for Amgen's latest earnings report can be read online. Read Transcript How much revenue does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded annual revenue of $33.42 billion. How much profit does Amgen generate each year? Amgen (NASDAQ:AMGN) has a recorded net income of $4.09 billion. AMGN has generated $10.96 earnings per share over the last four quarters. What is Amgen's price-to-earnings ratio? Amgen (NASDAQ:AMGN) has a trailing price-to-earnings ratio of 27.38 and a forward price-to-earnings ratio of 14.55. The price/earnings-to-growth ratio is 2.61. What is Amgen's EPS forecast for next year? Amgen's earnings are expected to grow from $20.62 per share to $21.39 per share in the next year, which is a 3.73% increase. More Earnings Resources from MarketBeat Related Companies Gilead Sciences Earnings Results Moderna Earnings Results Vertex Pharmaceuticals Earnings Results AbbVie Earnings Results Bristol Myers Squibb Earnings Results Johnson & Johnson Earnings Results Eli Lilly and Company Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Regeneron Pharmaceuticals Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk ProductionAmazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic? This page (NASDAQ:AMGN) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amgen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
